The National Cancer Institute (NCI) is offering this grant, the Outstanding Investigator Award (R35), to provide long-term support to accomplished investigators with outstanding records of cancer research productivity. This grant is for the purpose of enabling these investigators to propose and conduct exceptional research, encouraging them to take greater risks and explore adventurous lines of inquiry or develop new techniques. The OIA aims to provide extended funding stability, allowing institutions to nominate established Program Directors/Principal Investigators. It is expected that this will encourage researchers to embark on projects with unusual potential that can break new ground or extend discoveries, ultimately leading to breakthroughs that will advance biomedical, behavioral, or clinical cancer research.
Opportunity ID: 342746
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-045 |
| Funding Opportunity Title: | NCI Outstanding Investigator Award (R35 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 26, 2022 |
| Last Updated Date: | Jul 26, 2022 |
| Original Closing Date for Applications: | Nov 07, 2024 |
| Current Closing Date for Applications: | Nov 07, 2024 |
| Archive Date: | Dec 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $600,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Native American tribal governments (Federally recognized) Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education State governments Private institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-045.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342746 Full Announcement-RFA-CA-22-045 -> RFA-CA-22-045-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276184 | Oct 08, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278302 | Nov 10, 2022 | Nov 07, 2024 | View |
Package 1
Mandatory forms
342746 RR_SF424_5_0-5.0.pdf
342746 PHS398_CoverPageSupplement_5_0-5.0.pdf
342746 RR_OtherProjectInfo_1_4-1.4.pdf
342746 PerformanceSite_4_0-4.0.pdf
342746 RR_KeyPersonExpanded_4_0-4.0.pdf
342746 RR_Budget10_3_0-3.0.pdf
342746 PHS398_ResearchPlan_4_0-4.0.pdf
342746 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342746 RR_SubawardBudget10_30_3_0-3.0.pdf
342746 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
342746 RR_SF424_5_0-5.0.pdf
342746 PHS398_CoverPageSupplement_5_0-5.0.pdf
342746 RR_OtherProjectInfo_1_4-1.4.pdf
342746 PerformanceSite_4_0-4.0.pdf
342746 RR_KeyPersonExpanded_4_0-4.0.pdf
342746 RR_Budget10_3_0-3.0.pdf
342746 PHS398_ResearchPlan_5_0-5.0.pdf
342746 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342746 RR_SubawardBudget10_30_3_0-3.0.pdf
342746 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
